The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
Alkem has submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines.
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
